Advertisement

BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 600x60px
Document › Details

Thermo Fisher Scientific Inc.. (11/30/10). "Press Release: Thermo Fisher Signs Definitive Agreement to Acquire Lomb Scientific. Reinforces Commitment to Expand Market Presence in Australia and New Zealand". Waltham, MA.

Region Region Australia + New Zealand
Organisations Organisation Lomb Scientific Pty Ltd.
  Group Thermo Fisher (Group)
  Organisation 2 Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
Products Product reagents (bio/biochemical)
  Product 2 laboratory equipment and instruments
Index term Index term Lomb Scientific–Thermo Fisher: investment, 201011–201012 acquisition
Person Person Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring)
     


Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed a definitive agreement to acquire Lomb Scientific, a well-known provider of laboratory chemicals, consumables and instruments in Australia and New Zealand. Its customers include leading hospitals, universities, research and analytical laboratories in both countries, as well as a growing portion of Asia and the Middle East. Lomb has approximately 100 employees and had full year revenue of AUD $34 million in 2009.

"The addition of Lomb Scientific reinforces our commitment to expand in growing Asia Pacific markets," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "Through this acquisition, we would significantly strengthen our laboratory product offerings in the region, particularly chemicals used in life sciences, research and industrial applications. Lomb Scientific would also expand our customer base, increasing our depth of capabilities in health sciences, such as pathology, and building on our presence in strong industrial markets, such as mining."

Lomb Scientific produces a variety of laboratory chemicals and other consumables, and provides a comprehensive offering of instrumentation and services through its extensive commercial network. The business will be integrated into Thermo Fisher's Laboratory Products and Services and Analytical Technologies segments. Completion of the transaction is subject to applicable regulatory approvals and customary closing conditions.


About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit www.thermofisher.com.

The following constitutes a "Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company's Quarterly Report on Form 10-Q for the quarter ended October 2, 2010, under the caption "Risk Factors," which is on file with the Securities and Exchange Commission and available in the "Investors" section of our Website under the heading "SEC Filings." Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: competition and its effect on pricing, spending, third-party relationships and revenues; the need to develop new products and adapt to significant technological change; implementation of strategies for improving internal growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; the effect of changes in governmental regulations; the effect of laws and regulations governing government contracts; and the effect of competing with certain of our customers and suppliers. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if our estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.


Thermo Fisher Scientific Inc.

Media Contact Information:
Ron O'Brien, 781-622-1242
ron.obrien@thermofisher.com
www.thermofisher.com

or

Investor Contact Information:
Ken Apicerno, 781-622-1294
ken.apicerno@thermofisher.com

   
Record changed: 2016-03-19

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px

More documents for Thermo Fisher (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px BCNP Consultants European Chemistry Partnering 2017 Ffm Germany 120x180px Picture EBD Group BIO-Europe Spring 2017 BES Barcelona Spain March 120x180px Picture AB Sciex Berliner LCMSMS Symposium 2017 Right 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px